The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
2019 · Journal of Cancer Survivorship · 45 citations
https://doi.org/10.1007/s11764-019-00770-0
D
Donna Milne
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
1.3K
Citations
20
h-index
32
i10-index
Donna Milne is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Cancer survivorship and care & Palliative Care and End-of-Life Issues & Cancer Immunotherapy and Biomarkers. The author has an h-index of 20, co-authored 57 publications.
ORCID: 0000-0002-9874-2023Papers by this author
worksi-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol
2020 · BMJ Open · 18 citations
https://doi.org/10.1136/bmjopen-2019-036059
Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0–II) melanoma
2022 · BMJ Open · 6 citations
https://doi.org/10.1136/bmjopen-2021-054337
Identification of low health and cancer literacy in oncology patients: a cross-sectional survey
2021 · Supportive Care in Cancer · 5 citations
https://doi.org/10.1007/s00520-021-06164-2
Equity in cancer care: mixed methods clinical utility analysis of the Nursing Equity Assessment Tool (NEAT) to identify disadvantage in newly diagnosed cancer patients
2024 · Supportive Care in Cancer · 1 citations
https://doi.org/10.1007/s00520-024-09094-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat